Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Mouaz Al-Mallah,
View the Slides from this session in ESC Congress 365
The session addressed the role of advanced and innovative invasive and non invasive multimodality cardiac imaging in the assessment and management of patients with ischemic heart disease.
Dr. Luisa Salido Tahoce (Madrid, ES) started the session by highlighting some of the invasive tools. He reminded the audience that the current ESC guidelines recommend FFR for the assessment of intermediate lesions in patients without objective evidence of vessel-related myocardial ischemia (Class I, level of evidence A). In these cases, physiology guided PCI with FFR is the standard to evaluate if a stenosis is significant. However, the evidence for FFR comes mainly from patients with stable angina. In patients with acute coronary syndrome (ACS), other imaging modalities, like OCT which has excellent resolution, may be needed. Moreover, OCT allows for the identification of the culprit lesion which may be important in patients with ACS.
Dr. Thomas Schindler (Baltimore, US) reported on the role of PET and MRI in the assessment of myocardial viability. According to Dr Schindler, both techniques provide excellent and accurate assessment of viability. In addition, both techniques have prognostic data demonstrating the ability to predict functional recovery. Thus, Dr. Schindler believes that Integrated PET/MRI is likely to evolve as the reference imaging modality in cardiac viability assessment. However, the current data is limited and further studies are needed.
Continuing with the theme of innovative technology, Dr. Aliessa Gimelli (Pisa, IT) showed that the new ultrafast SPECT systems are at least as accurate as the conventional SPECT systems, with the added benefit of being much faster with much lower radiation exposure. Some patients can be scanned with doses less than 1 millisievert (mSv). She explained that these new systems may provide the possibility to quantify myocardial blood flow using SPECT imaging and that preliminary data appears to be promising.
Finally, Prof. Grigorios Korosoglou (Heidelberg, GE) reviewed the invasive and non invasive techniques for arterial vulnerable plaque imaging. He suggested that cardiac MR has tremendous potential as a research tool and may be optimally suited for serial studies. He also mentioned that the combination of CT with nuclear techniques (18F-NaF PET-CT) showed very promising results in the first human studies.
In summary, many innovative tools are starting to penetrate the clinical arena and will be used more often. Precise understanding of the role of these techniques (PET/MR, ultrafast SPECT and plaque imaging by MRI, coronary CTA and 18F-NaF PET-CT) and their incremental diagnostic and prognostic value is currently investigated and will shed further light on the utility of these tools.
Invasive and non-invasive cardiovascular multimodality imaging in ischaemic heart disease
© 2017 European Society of Cardiology. All rights reserved